Editorial Policy
How Pharma Quality System creates, reviews, and maintains its content.
Our goal is to publish clear, useful, and responsibly sourced educational content for readers interested in pharmaceutical quality and career development.
Last updated: August 23, 2026
Content is developed and maintained by the Pharma Quality System Editorial Team. The team page explains our editorial workflow, source hierarchy, review approach, use of digital tools, and correction process.
Our Editorial Principles
Pharma Quality System is built around four editorial priorities: accuracy, practical usefulness, transparent sourcing, and clarity.
We aim to explain pharmaceutical quality topics in a way that is understandable to students, job candidates, and professionals while preserving the technical meaning of the subject.
Source Selection
For regulatory, GMP, quality-system, and compliance-related topics, we prioritize primary or authoritative sources whenever they are available.
These may include:
- U.S. Food and Drug Administration (FDA)
- Health Canada
- International Council for Harmonisation (ICH)
- United States Pharmacopeia (USP)
- World Health Organization (WHO)
- European Commission / EU GMP guidance
- Other official regulatory or standards organizations when relevant to the topic
Secondary references may be used for context or explanation, but they should not replace an applicable primary regulatory source when the original source is available and relevant.
How Articles Are Developed
Depending on the topic, an article may be developed through a combination of:
- Topic definition: identifying the specific question, concept, or career need the article should answer.
- Source review: checking applicable official guidance, regulations, or recognized technical references.
- Structured drafting: organizing the content around the reader’s likely questions and practical use cases.
- Practical examples: adding simplified scenarios, comparisons, tables, or workflows where they improve understanding.
- Visual development: creating original diagrams, infographics, or animations when a visual explanation adds real educational value.
- Internal consistency review: checking terminology, links, examples, and relationships with other articles on the site.
- Post-publication updates: revising content when meaningful regulatory changes, factual corrections, or clarity improvements are identified.
Regulatory and Industry Context
Pharmaceutical requirements are not identical in every country, company, product type, dosage form, or manufacturing environment.
When we explain a concept such as CAPA, GMP, deviation management, Quality Control, validation, or data integrity, we aim to separate:
- Requirements or expectations supported by an identified authoritative source.
- Common pharmaceutical-industry practices that may vary between organizations.
- Simplified examples created for education and career preparation.
Readers should always consult the applicable current regulation, official guidance, approved procedure, and qualified internal personnel for decisions in a regulated workplace.
Corrections and Updates
We aim to correct meaningful factual errors when they are identified. Articles may also be updated to improve clarity, replace outdated references, add stronger sources, or reflect important changes in pharmaceutical guidance.
Where appropriate, a page may include an updated date or revised wording. Minor formatting or readability changes may not always be separately documented.
Use of Artificial Intelligence and Digital Tools
Digital tools, including AI-assisted tools, may be used to support research organization, drafting, editing, formatting, visual development, or content production.
Their use does not change our editorial standard: published material should be reviewed for relevance, clarity, consistency, and appropriate sourcing before publication.
We do not intentionally publish AI-generated text, images, or summaries as a substitute for checking important regulatory claims against credible sources.
Originality and Content Quality
We aim to create original educational value rather than reproduce or lightly rewrite material from other websites. Our articles may use established technical terminology, but the structure, examples, comparisons, visual explanations, and editorial presentation are developed for the needs of our readers.
We avoid keyword stuffing, misleading headlines, unsupported claims, and publishing large volumes of low-value content solely to target search traffic.
Independence
Editorial content is intended to remain educational and useful regardless of monetization. Advertising, sponsorship, or affiliate relationships should not determine the technical conclusions presented in an article.
If sponsored or affiliate content is introduced in the future, it should be disclosed clearly where applicable.
Educational Scope
Pharma Quality System provides educational and career-development information. Content on this website is not a substitute for official regulatory interpretation, legal advice, medical advice, professional certification, workplace training, or an employer’s approved procedures.
Questions or Corrections
We welcome reasonable feedback about factual accuracy, broken references, unclear explanations, or material that may need updating.
Readers can use our Contact page to submit feedback or correction requests.
Pharma Quality System Editorial Policy
This policy describes the editorial standards we aim to follow across our pharmaceutical quality and career-development content.
Comments
Post a Comment